Monitoring donor-derived cell-free DNA is a noninvasive means of detecting antibody-mediated rejection of a transplanted ...

A groundbreaking study has identified circulating cell-free DNA as a potential biomarker for predicting early relapse in ...

Traditional biomarkers used in kidney transplant care lack sensitivity and specificity for early detection Donor-derived cell-free DNA is used as a biomarker for detecting early graft rejection or ...

Use of a standardized cell-free (cf)DNA-sequencing and cancer-screening protocol detected cancer in nearly half of pregnant ...

Donor-derived cell-free DNA (dd-cfDNA) is a biomarker for (sub)clinical allograft injury and could be a tool for monitoring of lung allograft health across the (pre)clinical spectrum of CLAD. In this ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

At the 8-cell stage of mouse embryo development, the coordination between DNA unwinding and replication appears to improve. © ...

(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, ...

which are spurred by marks of damage in the EV-DNA to organize immune cell clusters that resist liver metastases. "This is a tumor suppressor mechanism that had not been described before ...

Dec. 17, 2024 — Researchers developed a fully open-source biomolecular structure prediction model that achieves state-of-the-art performance, at the level of AlpahFold3, in an effort to ...

The blood test is called cell-free DNA sequencing. It looks for fetal problems in DNA fragments shed from the placenta into the mother’s bloodstream. It also can pick up DNA fragments shed by ...